As of May 2, 2025, Scinai Immunotherapeutics Ltd.'s market capitalization has reached $2.60 M. According to our data, Scinai Immunotherapeutics Ltd. is the 44632th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Scinai Immunotherapeutics Ltd. has seen its market value drop from $11.20 M to $1.70 M since 2015, representing a total decrease of 84.82% and an annual compound decline rate (CAGR) of 18.34%.
Date
Market Cap
Change (%)
April 21, 2025
$1.70 M
-41.38%
December 31, 2024
$2.90 M
31.82%
December 29, 2023
$2.20 M
-60%
December 30, 2022
$5.50 M
-83.68%
December 31, 2021
$33.70 M
5.64%
December 31, 2020
$31.90 M
-65.85%
December 31, 2019
$93.40 M
199.36%
December 31, 2018
$31.20 M
72.38%
December 29, 2017
$18.10 M
60.18%
December 30, 2016
$11.30 M
0.89%
December 31, 2015
$11.20 M
Company Profile
Scinai Immunotherapeutics Ltd. was founded in 2003 in United States.
on the Nasdaq Stock Market.
With 31 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
As of May 2, 2025, Scinai Immunotherapeutics Ltd. (including the parent company, if applicable) has an estimated market capitalization of $2.60 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Scinai Immunotherapeutics Ltd. global market capitalization ranking is approximately 44632 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.